Humira buyers appeal AbbVie ruling to Seventh Circuit

Buyers of AbbVie’s arthritis treatment Humira (adalimumab) have appealed against an Illinois judge’s decision to dismiss their class action antitrust suit to the US Court of Appeals for the Seventh Circuit.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Abbvie faces multiple Humira antitrust suits

4 April 2019 AbbVie is now facing six antitrust class-action lawsuits which claim that the company illegally stopped competition for its arthritis treatment Humira.

Americas

Judge refuses to block pay-for-delay law pending appeal

13 January 2020 A judge has refused to temporarily block California’s ban on pay-for-delay deals while a group of generics manufacturers appeal against the judge’s earlier decision.

Biotechnology

ITC to investigate Alvotech’s Humira biosimilar

27 January 2022 The US International Trade Commission will investigate whether drug manufacturers used trade secrets to develop a biosimilar of AbbVie’s Humira.

More on this story

Americas

Abbvie faces multiple Humira antitrust suits

4 April 2019 AbbVie is now facing six antitrust class-action lawsuits which claim that the company illegally stopped competition for its arthritis treatment Humira.

Americas

Judge refuses to block pay-for-delay law pending appeal

13 January 2020 A judge has refused to temporarily block California’s ban on pay-for-delay deals while a group of generics manufacturers appeal against the judge’s earlier decision.

Biotechnology

ITC to investigate Alvotech’s Humira biosimilar

27 January 2022 The US International Trade Commission will investigate whether drug manufacturers used trade secrets to develop a biosimilar of AbbVie’s Humira.

More on this story

Americas

Abbvie faces multiple Humira antitrust suits

4 April 2019 AbbVie is now facing six antitrust class-action lawsuits which claim that the company illegally stopped competition for its arthritis treatment Humira.

Americas

Judge refuses to block pay-for-delay law pending appeal

13 January 2020 A judge has refused to temporarily block California’s ban on pay-for-delay deals while a group of generics manufacturers appeal against the judge’s earlier decision.

Biotechnology

ITC to investigate Alvotech’s Humira biosimilar

27 January 2022 The US International Trade Commission will investigate whether drug manufacturers used trade secrets to develop a biosimilar of AbbVie’s Humira.

More features

Bayer gains exclusive licence for heart drug in Japan

EPO delivers key Novo Nordisk, GSK and Inhibrx rulings

McGuireWoods expands team with ex-Novo Nordisk GC

Paul, Weiss swoops for senior duo from Weil, Gotshal

UPC bans Meril Life Sciences from selling infringing heart valve

SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic

Kathi Vidal to rejoin previous firm as partner following USPTO departure

GSK triumphs in EPO appeal, revoking Pfizer patent

Humira buyers appeal AbbVie ruling to Seventh Circuit

More on this story

Editor's picks

Editor's picks

More on this story

More on this story

More features